NCT06605755
Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants No drug interventions prevention Not Available recruiting NCT00619502
Study of Immunogenicity and Safety of a Booster Dose of DTaP-IPV-HB-PRP~T Combined Vaccine in Healthy Turkish Infants No drug interventions prevention 3 completed NCT01389687
Study of SP059 Given Subcutaneously as a Three-dose Primary and Booster Vaccination in Infants in Japan No drug interventions prevention 3 completed NCT01491087
Safety of PENTAXIM® Given as a Three-Dose Primary Vaccination at 2, 3, and 4 Months of Age in Infants in China prevention 4 completed NCT00348387
Immunogenicity and Safety of Imovax Polio in Chinese Infants Compared to Local OPV prevention 3 completed NCT02817451
DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected Infants prevention 3 completed NCT03818477
Environmental Surveillance (ES) for Polio and AMR Using the TaqMan Array Card No drug interventions Not Available Not Available unknown_status NCT00255047
Safety and Immune Response of Different Pediatric Combination Vaccines. prevention 3 completed NCT06460545
Phase IV Study of Concomitant Administration of the sIPV and HepA No drug interventions prevention 4 not_yet_recruiting NCT03870061
Evaluation of an Infant Immunization Encouragement Program in Nigeria No drug interventions prevention Not Available completed NCT03368885
Evaluation of Integrating MIYCN Interventions in Existing CGPP of PCI No drug interventions health_services_research Not Available completed NCT00662870
Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended Vaccine prevention 3 completed NCT04027036
Comparison of Immunogenicity of Inactivated Poliovirus Vaccine (IPV) Administered Intramuscularly or Intradermally No drug interventions prevention 2 completed NCT02005536
Study of IMOVAX POLIO® Subcutaneous as a Booster Vaccine in Pre-school Age Children in Japan prevention 4 completed NCT05083039
Observational Program, Study the Preventive Efficacy of the BiVac Polio Vaccine Against the Incidence of Acute Respiratory Infections, Including COVID-19 No drug interventions Not Available Not Available completed NCT05721274
Community Engagement and Conditional Incentives to Accelerate Polio No drug interventions prevention Not Available completed NCT01810731
Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya prevention 2 / 3 withdrawn NCT00401531
Comparison of a DTaP-IPV-HB-PRP~T Combined Vaccine to Infanrix™-Hexa, When Administered With Prevnar® in Thai Infants prevention 3 completed NCT03147560
Immunogenicity and Safety Evaluation of Different Sequential Immunization Strategies by Sabin IPV and bOPV in Chinese Infants No drug interventions prevention 4 completed NCT01697280
Polio NID and Routine EPI Integration Trial Pakistan No drug interventions health_services_research Not Available completed NCT06058429
Immunogenicity of After Primary Immunization and Booster Immunization of sIPV No drug interventions Not Available Not Available active_not_recruiting NCT00802867
Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™ prevention 4 completed NCT00932269
Seroimmunity 2007 and Sub Study of the Swedish Population Regarding Vaccine Preventable Disease No drug interventions Not Available Not Available unknown_status NCT06114810
Immunogenicity of Novel Oral Poliovirus Vaccine Type 2 (nOPV2), bOPV and IPV No drug interventions prevention 4 not_yet_recruiting NCT01908114
To Develop, Implement and Evaluate the Polio Demonstration Project Comprising of a Community Based Intervention Package for Polio Eradication in Pakistan prevention 4 unknown_status NCT00855855
Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease Not Available Not Available completed NCT00315055
Immunogenicity of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® at 2-3-4 Months Schedule prevention 3 completed NCT04232943
Inactivated Poliovirus Vaccine (IPV) With or Without E.Coli Double Mutant Heat-Labile Toxin (dmLT) Challenge Study in Healthy Adults prevention 1 completed NCT05850364
A Multi-center, Open-labelled, Randomized, Controlled, Extended Phase Ⅲ Clinical Trial of sIPV Vaccine No drug interventions prevention 3 recruiting NCT01244464
A Study of the Safety of IMOVAX Polio™ in China prevention 4 completed NCT01278433
A Safety Study of IMOVAX Polio Vaccine in Selected Cities in China prevention 4 completed NCT04264598
Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine No drug interventions prevention 1 completed NCT03922061
Evaluation of Safety, Reactogenicity and Immunogenicity of Fractional-dose Inactivated Polio Vaccine (fIPV) Given Intradermally With Double Mutant Enterotoxigenic Escherichia Coli Heat Labile Toxin (dmLT) Adjuvant No drug interventions prevention 1 completed NCT00772928
Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™ prevention 3 completed NCT01346293
Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age prevention 3 completed NCT01841671
Immunogenicity of 1 or 2 Doses of bOPV in Chilean Infants Primed With IPV Vaccine treatment 4 unknown_status NCT04177485
Evaluating a Caregiver SMS Reminder Intervention to Reduce Immunization Drop-out in Arua, Uganda No drug interventions prevention Not Available completed NCT00259337
Immunogenicity and Safety of Pentaxim™ in an Indian Population prevention 3 completed NCT00514059
Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine No drug interventions prevention 4 completed NCT01559636
Diarrhea and Bivalent Oral Polio Vaccine Immunity diagnostic Not Available completed NCT00362336
Comparison of DTaP-IPV-Hep B-PRP~T Combined Vaccine to CombAct-HIB® Concomitantly Given With Engerix B® Paediatric and OPV prevention 3 completed NCT00254917
Assessment of the Immunogenicity and Safety of PENTAXIM™ in Philippines prevention 4 completed NCT02111135
Safety Study of a Single Dose of Monovalent High-dose Inactivated Poliovirus Type 2 Vaccine (m-IPV2 HD) in Infants Early in Life No drug interventions treatment 2 completed NCT01475539
Sequential Inactivated Poliomyelitis Vaccine Followed by Oral Poliomyelitis Vaccine Versus Oral Poliomyelitis Vaccine prevention 4 completed NCT01579825
Evaluation of Buffer on Immune Response to Oral Polio Vaccine (OPV) in Bangladesh No drug interventions prevention Not Available completed NCT02376374
OPV Transmissibility in Communities After Cessation of Routine OPV Immunization No drug interventions other Not Available completed NCT00362427
Study of PR5I, a Pediatric Combination Vaccine With Enhanced Hepatitis B Component Given Concomitantly With Prevnar® prevention 2 completed NCT06162104
Evaluation of Fatigue Severity, Mood, and Quality of Life in Post-Polio Syndrome No drug interventions Not Available Not Available completed NCT01586572
Pakistan Short Interval mOPV1 Compared With Standard Interval mOPV1 and bOPV 1,3 prevention Not Available completed NCT06218368
A Tool Kit to Improve Vaccine Confidence in the Philippines No drug interventions health_services_research Not Available recruiting NCT00772369
Retrospective Survey of Safety of Fourth Dose Pentacel® in Children No drug interventions Not Available Not Available completed NCT04264546
Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine (Phase Ib) No drug interventions prevention 1 / 2 completed NCT04576910
Immunogenicity and Safety of the Booster Dose of Polio Vaccine With Different Primary Sequential Schedules in China No drug interventions prevention 4 completed NCT05684081
Effect of Digital Payment to Campaign Health Workers on Vaccination Coverage No drug interventions health_services_research Not Available active_not_recruiting NCT03341195
Mobile Phone SMS Messages and Automated Calls in Improving Vaccine Coverage Among Children in Pakistan No drug interventions prevention Not Available unknown_status NCT06618196
Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age No drug interventions prevention 2 not_yet_recruiting NCT04579510
Immunogenicity nOPV2 With and Without bOPV No drug interventions other 2 completed NCT04529538
Study of Novel Types 1 and 3 Oral Poliomyelitis Vaccines prevention 1 completed NCT05431933
Study to Evaluate Eupolio(IPV)'s Safety, Long-term Protective Effect and Boosting Effect of One Booster Dose in the Three Primary Vaccination Plus Boosting Schedule, and Protective Effect in the Schedule with Bivalent OPV in Infants No drug interventions prevention 3 active_not_recruiting NCT01031303
Immunogenicity and Safety of TETRAXIM™ Given as a Booster Dose at 4 to 6 Years of Age prevention 4 completed NCT01751503
Extramembranous and Interosseous Technique of Tibialis Posterior Tendon Transfer No drug interventions treatment Not Available terminated NCT01048190
The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains No drug interventions prevention 1 completed NCT02422264
Immunogenicity and Safety Study of Infanrix Hexa in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery prevention 4 completed NCT06137664
Study of Trivalent and Bivalent (Types 1 & 2) Novel Oral Poliomyelitis Vaccines No drug interventions prevention 1 / 2 not_yet_recruiting NCT00355121
Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL® prevention 2 completed NCT00343421
Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered With Prevenar® in Infants and Toddlers prevention 3 completed NCT00255021
Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand prevention 4 completed NCT03614702
Clinic Trial to Evaluate the Safety and Immunogenicity by Different Sequential Schedules of bOPV and IPV prevention 3 completed NCT05644184
Study of a Novel Type 1 Oral Poliomyelitis Vaccine in Bangladesh No drug interventions prevention 2 recruiting NCT01248884
Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744) prevention 2 completed NCT01229579
Effect of Zinc Supplementation on Response to Oral Polio Vaccine in Infants in Pakistan basic_science Not Available completed NCT00258843
Safety of Imovax Polio in Chinese Infants and Children prevention 3 completed NCT04080687
Effect of Ankle-foot Orthoses on Balance Confidence No drug interventions Not Available Not Available completed NCT02094833
DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed Infants prevention 3 completed NCT05460377
Assessing Immunogenicity of Intramuscular Sabin Inactivated Poliovirus Vaccine and Non-inferiority of Intradermal Fractional Inactivated Poliovirus Vaccine No drug interventions prevention 4 active_not_recruiting NCT00316147
Immunogenicity & Safety of GSK's Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants at 2 Diff Vaccination Schedules prevention 3 completed NCT01323647
Immunogenicity and Safety of Booster Dose of PoliorixTM Vaccine in Previously Vaccinated Toddlers prevention 3 completed NCT05303545
Physical Activity in People With Sequelae of Poliomyelitis No drug interventions Not Available Not Available recruiting NCT01571505
Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in INDIA (PROVIDE) basic_science 1 completed NCT01056705
The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains (IPV) No drug interventions prevention 2 completed NCT01249183
Safety and Immunogenicity Study of Concomitant Versus Non Concomitant Administration of a Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine (REPEVAX) and Influenza Vaccine (VAXIGRIP) in Subjects Aged From 60 Years Old prevention 3 completed NCT04618783
Cross-neutralization Capacity of Immune Serum From Different Dosage of Sabin Inactivated Poliovirus Vaccine Immunization No drug interventions prevention Not Available completed NCT02458183
Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS No drug interventions prevention 3 completed NCT05033561
Study to Evaluate Safety and Immunogenicity of nOPV2 at Different Intervals in Infants No drug interventions prevention 3 completed NCT05163561
Evaluation of Safety and Immunogenicity of Inactivated Adjuvanted Polio Vaccine in Comparison With Licensed Inactivated Poliovirus Vaccine No drug interventions prevention 3 completed NCT00337428
Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diptheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents (V501-024)(COMPLETED) No drug interventions prevention 3 completed NCT00964028
Safety Study of GSK Biologicals' DTPa-IPV/Hib (Infanrix™-IPV/Hib) prevention 3 completed NCT00635128
Safety and Immunogenicity of a Booster Dose of GSK Biological's Boostrix-Polio Vaccine prevention 4 completed NCT01021293
Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Poliorix™ Vaccine No drug interventions prevention 3 completed NCT01094171
Study to Evaluate the Safety of Co-administration of GSK Biologicals' Poliorix and Infanrix in Healthy Children in Russia prevention 4 completed NCT01546909
Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRE No drug interventions prevention 4 completed NCT02274285
DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Infants No drug interventions prevention 3 completed NCT00001185
Study of "Post-Polio Syndrome" No drug interventions Not Available Not Available completed NCT03723837
Persistence of IPV Immunity No drug interventions prevention 4 completed NCT01997632
Phase 1 Study on the Safety and Reactogenicity of a Single Dose of Monovalent High-dose Inactivated Poliovirus Type 2 Vaccine (m-IPV2 HD) Given Intramuscularly Compared to Standard Trivalent Inactivated Poliovirus Vaccine (IPV) in Healthy Adults prevention 1 completed NCT00319852
Immunogenicity and Safety of Tetraxim Versus Local DTP + IPV prevention 3 completed NCT00611559
Study of a New Formulation of DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old Children prevention 4 completed NCT04073459
Safety and Immunogenicity of Hexavalent Vaccine(DTwP-HepB-IPV-Hib) in Healthy Infants No drug interventions prevention 2 unknown_status NCT01323959
Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults No drug interventions prevention 4 completed NCT00453570
Immunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 Months prevention 3 completed NCT02775942
Safety and Immunogenicity of IPOVAC in Young Children No drug interventions prevention 2 completed NCT00432042
Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035) prevention 3 completed NCT01870206
Randomized Clinical Trial to Evaluate Immunogenicity and Safety in Mexicans Newborns No drug interventions Not Available 3 unknown_status NCT03430349
Phase 1 Novel Live Attenuated Serotype 2 Oral Polio Vaccine Study in Inactivated Polio Vaccine (IPV) Primed Adults No drug interventions prevention 1 completed NCT06442449
Booster Dose of sIPV Co-administered With MMR and HepA-I. No drug interventions prevention 4 not_yet_recruiting NCT00753649
Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants prevention 4 completed NCT02040636
Study of Tetanus and Diphtheria Toxoids Adsorbed Combined With Component Pertussis Vaccine and Inactivated Poliomyelitis prevention 2 completed NCT03202719
Duration of IPV Priming and Antibody Decay No drug interventions prevention 4 completed NCT03597919
A Study of Immunogenicity and Seroconversion With Sabin IPV Schedules in China. No drug interventions prevention 4 completed NCT04224519
Consistency Study for Three Commercial Lots of Inactivated Poliomyelitis Vaccine Made From Sabin Strain No drug interventions prevention 4 completed NCT00871741
Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age. prevention 2 terminated NCT03821441
Trail To Evaluate the Immune Effects of Primary and Booster Immunizations With Poliovirus Vaccine prevention 3 unknown_status NCT03671616
Immunogenicity and Safety of Adjuvanted Reduced Dose Inactivated Polio Vaccine Given as a Booster at Age 15-18 Months No drug interventions other 3 completed NCT00303316
Immunogenicity Study of Antibody Persistence and Booster Effect of PENTAXIM™ at 18 Months in Healthy Argentinean Infants prevention 3 completed NCT00137696
Comparison of Immune Response Using 2 Vaccination Schedules Using Inactivated Polio Vaccine No drug interventions other Not Available completed NCT03239496
A Study to Evaluate Immunogenicity of Intramuscular Full-Dose and Intradermal Fractional Dose of IPV No drug interventions prevention 3 completed NCT03891758
Confirmatory Study of BK1310 in Healthy Infants prevention 3 completed NCT00146835
Post-marketing Safety Study of GSK Biological's Pediarix™ Vaccine Not Available Not Available completed NCT00320463
Compare Immunogenicity & Safety of 2 Formulations of GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine Given in Healthy Infants prevention 3 completed NCT00352963
Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age). No drug interventions prevention 3 completed NCT02291263
Immunogenicity of Intramuscular Inactivated Poliovirus Vaccine No drug interventions prevention 3 completed NCT01177722
A Study of DTaP-IPV-Hep B-PRP-T Vaccine Given With Prevenar™ and Rotarix™ in Healthy Latin American Infants prevention 3 completed NCT03169725
A Clinical Study to Evaluate the Safety and Immunogenicity of Inactivated Poliomyelitis Vaccine in Healthy Infants No drug interventions prevention 2 / 3 completed NCT01358825
Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexa™ or Infanrix-IPV/Hib™ No drug interventions prevention 4 completed NCT00447525
REVAXIS® Versus DT Polio® as a Second Booster in 6 Year-old Children prevention 3 completed NCT00885157
Immunogenicity and Safety of a Fractional Booster Dose of IPV Intradermally Versus Full Dose Intramuscularly prevention 2 completed NCT02847026
Fractional Inactivated Poliovirus Vaccine Booster and Rotavirus Study prevention 4 completed NCT01510366
The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains(Sabin IPV) No drug interventions prevention 3 completed NCT00304265
Post-marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis Vaccine No drug interventions prevention 4 completed NCT02985320
Studies of the Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine No drug interventions prevention 1 / 2 completed NCT05166031
Evaluation of the Immunogenicity and Safety of Concomitant Administration of Novel Oral Polio Type 2 Vaccine and Bivalent Oral Polio Vaccine No drug interventions prevention 3 withdrawn NCT04989231
An Immunity Persistence Study of Sabin Inactivated Poliovirus Vaccine(Vero Cell) After Four Doses No drug interventions Not Available Not Available completed NCT06101173
A Study to Evaluate the Safety and Immunogenicity of Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) in Healthy Adults No drug interventions prevention 1 active_not_recruiting NCT00879827
Immunogenicity and Reactogenicity of GSK Bio DTPa-HBV-IPV and Hib Vaccines When Coadministered to Healthy Infants prevention 3 completed NCT01568060
Post-marketing Surveillance to Assess the Safety of Infanrix-IPV Vaccine Among Infants and Children in Korea No drug interventions Not Available Not Available completed NCT03092791
IPV-102 Safety, Tolerability and Immunogenicity of TAK-195 in Healthy Infants, Toddlers and Adults No drug interventions prevention 1 / 2 terminated NCT02089880
Comparing Functional Outcomes in Individuals Using Micro-processor Controlled Orthosis Versus Stance Control Orthosis No drug interventions supportive_care Not Available active_not_recruiting NCT03128489
Evaluation of Immunogenicity and Safety of DTPa-IPV/Hib Conjugate Vaccine (Infanrix™-IPV/Hib) Administered at 6, 10 and 14 Weeks in Healthy Indian Infants prevention 3 withdrawn NCT01171989
Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose prevention 2 completed NCT00287092
Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule in Infants prevention 3 completed NCT03822767
A Clinical Trial to Evaluate the Immunogenicity and Safety of sIPV in a "2+1"Sequential Schedule With bOPV in Infants No drug interventions prevention 3 completed NCT00307567
Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated in Study 103488 No drug interventions prevention 2 completed NCT02580201
A Study to Evaluate Safety and Immunogenicity of tOPV in 1 to 5 Years and at 6 Weeks of Age prevention 4 completed NCT00654901
Study of the DTaP-IPV-Hep B-PRP~T Combined Vaccine Following a Primary Series of DTacP IPV-HepB-PRP-T or Infanrix Hexa™ prevention 3 completed NCT01847872
IPV Clinical Trial - The Gambia No drug interventions prevention 4 completed NCT00254969
Immunogenicity and Safety of Pentaxim in South African Infants prevention 3 completed NCT01309646
Immunogenicity and Safety of GlaxoSmithKline Biologicals' Infanrix™-IPV+Hib Vaccine prevention 3 completed NCT05457946
Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series No drug interventions prevention 2 / 3 not_yet_recruiting NCT05386810
Safety of Sabin Inactivated Poliovirus Vaccine in Adults, Children and Infants and Lot Consistency Immunogenicity, and Safety of the msIPV in 2 Months Old Infants No drug interventions prevention 3 completed NCT02582255
A Study to Evaluate the Safety and Immunogenicity of Monovalent OPV2 in Children Aged 1 to 5 Years in Lithuania No drug interventions prevention 4 completed NCT01831050
Safety and Immunogenicity of 1 or 2 Doses of IPV in Latin American Infants Primed With Bivalent OPV Vaccine prevention 4 completed NCT03025750
Safety and Immunogenicity of Adjuvanted Reduced Dose Inactivated Polio Vaccine in 2, 4, 6 Months of Age No drug interventions other 3 completed NCT04063150
Immunogenicity of Intramuscular and Intradermal IPV No drug interventions other 4 terminated NCT01086423
Immunogenicity and Safety Study of GSK Biologicals' Infanrix-IPV+Hib™ Vaccine prevention 3 completed NCT02347423
3 Adjuvated Reduced Dose IPV-Al SSI and Non-adjuvated Full Dose IPV SSI Given as Primary Vaccinations to Infants No drug interventions prevention 2 completed NCT01457508
Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered Separately prevention 3 completed NCT00325143
Safety of DTPa-IPV/Hib & DTPa-HBV-IPV/Hib, Followed by DTPa-IPV/Hib Vaccine in Infants Who Received Hepatitis B Vaccine prevention 3 completed NCT03286803
Comparison of Immunity Following IPV Versus fIPV: a Community Based Randomized Controlled Trial in Pakistan No drug interventions prevention 4 unknown_status NCT01353703
Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine prevention 3 completed NCT00376779
Immunogenicity and Safety of a DTPa-HBV-IPV/Hib Vaccine Given at 2, 3 and 4 Months of Age prevention 2 completed NCT04544787
A Phase 2 Study to Evaluate the Safety and Immunogenicity of Two Oral Poliovirus Vaccine Candidates No drug interventions prevention 2 completed NCT00514033
A Post-marketing Safety Study of GSK Bio IPV Vaccine (PoliorixTM) in Korean Children No drug interventions Not Available Not Available completed NCT03822754
A Clinical Trial to Evaluate the Immunogenicity and Safety of sIPV in a '1+2' Sequential Schedule With bOPV in Infants No drug interventions prevention 3 completed NCT00404651
Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Infants prevention 3 completed NCT01090453
Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants prevention 2 completed NCT01457547
Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination Course prevention 4 completed NCT00133445
Pentavalent DTaP-Hep B-IPV No drug interventions prevention 2 completed NCT06577298
A Study to Evaluate the Safety and Immunogenicity of VLP-Polio in Infants and Toddlers No drug interventions prevention 1 / 2 not_yet_recruiting NCT03554798
A Study to Evaluate the Safety and Immunogenicity of Novel Oral Polio Vaccine prevention 2 completed NCT01453998
Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744) prevention 2 completed NCT02785705
Randomized Controlled Trial for Immunogenicity and Safety Evaluation of Bivalent Types 1 and 3 Oral Poliovirus Vaccine No drug interventions prevention 3 completed NCT03890497
Assessment of Poliovirus Type 2 Immunogenicity of One and Two Dose Schedule With IPV and fIPV When Administered at 9-13 Months of Age in Bangladesh No drug interventions prevention 4 unknown_status NCT04614597
A Study on Immunity Duration Against Polio Over 18 Months Infants After 2 or 3 Primary Doses Sabin IPV in China No drug interventions Not Available Not Available completed NCT02967783
A Campaign-based ID fIPV Administration Trial No drug interventions device_feasibility Not Available completed NCT02189811
Polio End-game Strategies - Poliovirus Type 2 Challenge Study No drug interventions prevention 4 completed NCT00831311
Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinean Infants prevention 2 completed NCT00797511
Immunogenicity and Safety of Adacel Polio Vaccine prevention 3 completed NCT01948193
Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine in Indian Infants Previously Given a Dose of Hepatitis B Vaccine at Birth prevention 3 completed NCT01709071
Safety and Immunogenicity of a New Inactivated Poliovirus Vaccine in Infants No drug interventions prevention 1 / 2 completed NCT03526978
An Immunogenicity and Safety Study of Sabin Inactivated Poliovirus Vaccine (Vero Cell) in 2-month-old Infants No drug interventions prevention 3 completed NCT00970307
Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age prevention 2 completed NCT04386707
Lot-consistency Clinical Trial of Sabin Strain Inactivated Polio Vaccine No drug interventions prevention 3 completed NCT00325156
Assess the Safety & Reactogenicity of DTPa-IPV/Hib Vaccine Administered at 3, 4, 5 & 18 Mths of Age, in Healthy Infants prevention 4 completed NCT05677256
A Study to Evaluate Pharyngeal Immunity to Poliovirus Type-2 No drug interventions prevention 4 completed NCT05951985
High Intensity Functional Training for Individuals With Neurologic Diagnoses and Their Care Partners No drug interventions treatment Not Available recruiting NCT04220515
Inactivated Poliomyelitis Vaccine Made From Sabin Strain No drug interventions prevention 4 completed NCT00463437
Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines prevention 3 completed NCT04448132
Evaluation of Persistence of Immunity in 4-year-old Children Previously Immunised With IPV-Al AJV (Picovax®) No drug interventions prevention 4 completed NCT02231632
The Immunogenicity and Safety of Live Attenuated Poliomyelitis Vaccine (Human Diploid Cell) No drug interventions prevention 2 / 3 completed NCT01577732
Safety of GSK Biologicals' Infanrix-IPV+HibTM Vaccine in Healthy Vietnamese Toddlers prevention 3 completed NCT00871000
Immunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-year-old Children. prevention 3 completed NCT01105559
Antibody Persistence in Healthy Children After Primary and Booster DTaP-IPV-Hep B-PRP-T Vaccine or Control Vaccine No drug interventions Not Available Not Available completed NCT02434770
Immunogenicity and Safety of Liquid Bivalent Oral Poliomyelitis Vaccine No drug interventions prevention 3 completed NCT01245049
Immunogenicity and Safety of GSK Biologicals' Boostrix Polio Vaccine in 3 and 4-year-old Children prevention 3 completed NCT03016949
A Study to Evaluate Immunogenicity of Various Schedules of Inactivated Polio Vaccine No drug interventions prevention 3 withdrawn NCT01287949
Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or Older prevention 3 completed NCT01573936
Quality of Life in Adult Neurological Patients No drug interventions treatment Not Available completed NCT03032419
Safety and Immunogenicity of Adjuvanted Reduced Dose Inactivated Polio Vaccine Given at 6, 10, 14 Weeks and 9 Months No drug interventions other 3 completed NCT05432141
A Safety Study of Sabin Inactivated Poliovirus Vaccine in Infants No drug interventions prevention 4 completed NCT06346834
Sequential Vaccination of Poliomyelitis Vaccine (Vero Cells), Inactivated, Sabin Strains From Different Manufacturers No drug interventions prevention 4 not_yet_recruiting NCT03546634
Sero-conversion Study for a Two-dose Schedule of Sabin IPV in China No drug interventions prevention 4 completed NCT05952596
A Study to Evaluate Safety and Immunogenicity of APV006 in Healthy Adults No drug interventions prevention 1 not_yet_recruiting NCT00627458
Immunogenicity and Reactogenicity of a Booster Dose of GSK Bio's DTPa-HBV-IPV/Hib Vaccine prevention 2 completed NCT00604058
Immunogenicity and Safety of Fractional Doses of IPV Intradermally vs Full Doses Intramuscularly prevention 2 completed NCT04432935
Effect of Lactoferrin on Polio Seroconversion No drug interventions prevention Not Available completed NCT02096263
Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants prevention 3 completed NCT04693286
Clinical Trial of Novel OPV2 Vaccine No drug interventions prevention 2 completed NCT00920439
Safety and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' IPV Vaccine (PoliorixTM) in Toddlers No drug interventions prevention 3 completed NCT05327426
Intradermal Fractional Dose IPV (fIPV) in Combination With dmLT No drug interventions prevention 1 active_not_recruiting NCT01708720
Safety and Immunogenicity of a New Inactivated Polio Vaccine in Healthy Adults No drug interventions prevention 1 completed NCT01457560
Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib Vaccine Followed by the Same Vaccine and Oral Polio Vaccine prevention 3 completed NCT02428491
Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After Birth prevention 3 completed NCT02853929
Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery prevention 4 completed NCT01214889
Study of PENTAXIM™ Vaccine Versus TETRAXIM™ Vaccine Given With ACTHIB™ Vaccine in South Korean Infants. prevention 3 completed NCT04618640
To Evaluate the Immunogenicity and Safety of DTaP-IPV Vaccine Administered as a Boosting Dose to Healthy Children of 4-6 Years No drug interventions prevention 3 unknown_status NCT01983540
Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination prevention 3 completed NCT05654467
Study of a Novel Type 3 Oral Poliomyelitis Vaccine in Panama No drug interventions prevention 2 recruiting NCT03208101
A Study to Compare LBVD to Eupenta and Imovax Polio in Healthy Adults No drug interventions prevention 1 completed NCT01813604
Immunogenicity of Inactivated and Live Polio Vaccines prevention 3 completed NCT00937404
Safety and Reactogenicity of GSK Biologicals' Inactivated Poliomyelitis Vaccine (IPV) (Poliorix) in Infants No drug interventions prevention 1 completed NCT03722004
Monovalent Oral Poliovirus Vaccine Type 1 Intestinal and Humoral Immunity Study No drug interventions other 4 completed NCT00138268
Pilot Study Freeze and Transport Immune Cells No drug interventions Not Available Not Available completed NCT02643368
Immunogenicity of Monovalent Type 2 Oral Poliovirus Vaccine No drug interventions prevention 4 completed NCT00092469
Study of an Investigational Vaccine in Healthy Infants in Taiwan (V441-001)(COMPLETED) prevention 3 completed NCT02643446
Serological Survey on Monitoring the Positive Rate After Vaccination of Inactivated Polio Vaccine No drug interventions Not Available Not Available completed NCT01444781
Study of the Booster Effect of DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa™ and Prevenar™ in Healthy Infants prevention 3 completed NCT01457495
Immunogenicity and Safety of DTPa-HBV-IPV/Hib Compared to DTPa-IPV/Hib and HBV Administered Concomitantly prevention 2 completed NCT02412514
Intestinal and Humoral Immunity of Sequential Polio Vaccination Schedules No drug interventions prevention 4 completed NCT01437423
Regulatory Post-Marketing Surveillance Study for TETRAXIM™ prevention 4 completed